S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
S&P 500   4,179.83 (-0.61%)
DOW   32,908.27 (-0.41%)
QQQ   347.99 (-0.57%)
AAPL   177.25 (-0.03%)
MSFT   328.39 (-0.85%)
META   264.72 (+0.84%)
GOOGL   122.87 (-0.65%)
AMZN   120.58 (-0.89%)
TSLA   203.93 (+1.38%)
NVDA   378.34 (-5.68%)
NIO   7.53 (+1.62%)
BABA   79.58 (+1.16%)
AMD   118.21 (-5.64%)
T   15.73 (+0.58%)
F   12.00 (-4.69%)
MU   68.20 (-4.87%)
CGC   0.84 (-2.34%)
GE   101.53 (-0.86%)
DIS   87.96 (+0.16%)
AMC   4.51 (-2.59%)
PFE   38.02 (+2.73%)
PYPL   61.99 (-0.10%)
NFLX   395.23 (+0.57%)
NASDAQ:ACMR

ACM Research (ACMR) Stock Forecast, Price & News

$10.11
-0.10 (-0.98%)
(As of 05/31/2023 ET)
Compare
Today's Range
$9.65
$10.19
50-Day Range
$8.88
$12.20
52-Week Range
$5.46
$20.24
Volume
1.49 million shs
Average Volume
747,244 shs
Market Capitalization
$554.53 million
P/E Ratio
12.80
Dividend Yield
N/A
Price Target
$18.00

ACM Research MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
78.9% Upside
$18.00 Price Target
Short Interest
Healthy
4.07% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.21mentions of ACM Research in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$730,575 Sold Last Quarter
Proj. Earnings Growth
5.06%
From $0.79 to $0.83 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.88 out of 5 stars

Computer And Technology Sector

36th out of 621 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

2nd out of 14 stocks


ACMR stock logo

About ACM Research (NASDAQ:ACMR) Stock

ACM Research, Inc. engages in the development, manufacture, and sale of single-wafer wet cleaning equipment. It supplies process solutions that semi conductor manufacturers can use in numerous manufacturing steps to remove particles, contaminants and other random defects, and thereby improve product yield. The company tools can be used in fabricating foundry, logic and memory chips including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company was founded by David H. Wang and Hui Wang in January 1998 and is headquartered in Fremont, CA.

Receive ACMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ACM Research and its competitors with MarketBeat's FREE daily newsletter.

ACMR Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Acm Research (NASDAQ: ACMR)
ACM Research (NASDAQ:ACMR) Shares Gap Down to $10.47
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
ACM Research Reports First Quarter 2023 Results
ACM Research (NASDAQ:ACMR) Stock Price Up 4.9%
ACM Research (NASDAQ:ACMR) Stock Price Up 3.7%
Craig-Hallum Keeps Their Buy Rating on ACM Research (ACMR)
See More Headlines
Receive ACMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ACM Research and its competitors with MarketBeat's FREE daily newsletter.

ACMR Company Calendar

Last Earnings
11/04/2021
Today
5/31/2023
Next Earnings (Estimated)
8/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Special industry machinery, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:ACMR
Employees
1,209
Year Founded
1997

Price Target and Rating

Average Stock Price Forecast
$18.00
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+78.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$39.26 million
Pretax Margin
21.54%

Debt

Sales & Book Value

Annual Sales
$388.83 million
Cash Flow
$0.91 per share
Book Value
$15.18 per share

Miscellaneous

Free Float
36,225,000
Market Cap
$554.53 million
Optionable
Not Optionable
Beta
1.15

Social Links


Key Executives

  • David H. WangDavid H. Wang
    President, Chief Executive Officer & Director
  • Mark McKechnieMark McKechnie
    Chief Financial Officer, Secretary & Treasurer
  • Jim Straus
    Vice President-Sales













ACMR Stock - Frequently Asked Questions

Should I buy or sell ACM Research stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ACM Research in the last year. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACMR shares.
View ACMR analyst ratings
or view top-rated stocks.

What is ACM Research's stock price forecast for 2023?

4 brokerages have issued 1 year price objectives for ACM Research's shares. Their ACMR share price forecasts range from $8.00 to $32.00. On average, they predict the company's share price to reach $18.00 in the next twelve months. This suggests a possible upside of 78.0% from the stock's current price.
View analysts price targets for ACMR
or view top-rated stocks among Wall Street analysts.

How have ACMR shares performed in 2023?

ACM Research's stock was trading at $7.71 at the beginning of 2023. Since then, ACMR stock has increased by 31.1% and is now trading at $10.11.
View the best growth stocks for 2023 here
.

Are investors shorting ACM Research?

ACM Research saw a increase in short interest in May. As of May 15th, there was short interest totaling 2,230,000 shares, an increase of 7.7% from the April 30th total of 2,070,000 shares. Based on an average daily trading volume, of 646,100 shares, the days-to-cover ratio is currently 3.5 days.
View ACM Research's Short Interest
.

When is ACM Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 4th 2023.
View our ACMR earnings forecast
.

How were ACM Research's earnings last quarter?

ACM Research, Inc. (NASDAQ:ACMR) released its quarterly earnings results on Thursday, November, 4th. The specialty retailer reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.07. The specialty retailer earned $67 million during the quarter, compared to analyst estimates of $67.20 million. ACM Research had a net margin of 12.40% and a trailing twelve-month return on equity of 7.09%. ACM Research's revenue for the quarter was up 40.5% on a year-over-year basis. During the same period last year, the company posted $0.14 earnings per share.

What ETFs hold ACM Research's stock?

ETFs with the largest weight of ACM Research (NASDAQ:ACMR) stock in their portfolio include Invesco Nasdaq Future Gen 200 ETF (QQQS), Janus Henderson Small Cap Growth Alpha ETF (JSML), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD),

When did ACM Research's stock split?

ACM Research's stock split on Thursday, March 24th 2022. The 3-1 split was announced on Thursday, March 24th 2022. The newly issued shares were issued to shareholders after the market closes on Thursday, March 24th 2022. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What guidance has ACM Research issued on next quarter's earnings?

ACM Research issued an update on its FY 2023 earnings guidance on Sunday, May, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $515.00 million-$585.00 million, compared to the consensus revenue estimate of $540.63 million.

What other stocks do shareholders of ACM Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ACM Research investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), QUALCOMM (QCOM), Walt Disney (DIS), Block (SQ), Marvell Technology (MRVL), Taiwan Semiconductor Manufacturing (TSM) and AbbVie (ABBV).

When did ACM Research IPO?

(ACMR) raised $17 million in an IPO on Friday, November 3rd 2017. The company issued 2,000,000 shares at a price of $7.50-$9.50 per share. Roth Capital Partners acted as the underwriter for the IPO and Craig-Hallum Capital Group and The Benchmark Company were co-managers.

What is ACM Research's stock symbol?

ACM Research trades on the NASDAQ under the ticker symbol "ACMR."

Who are ACM Research's major shareholders?

ACM Research's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (5.89%), State Street Corp (1.67%), Hotchkis & Wiley Capital Management LLC (1.63%), Pertento Partners LLP (1.62%), Geode Capital Management LLC (1.59%) and JPMorgan Chase & Co. (1.48%). Insiders that own company stock include Chenming Hu, David H Wang, Fuping Chen, Haiping Dun, Jian Wang, Lisa Feng, Mark Mckechnie, Sotheara Cheav, Tracy Liu and Yinan Xiang.
View institutional ownership trends
.

How do I buy shares of ACM Research?

Shares of ACMR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ACM Research's stock price today?

One share of ACMR stock can currently be purchased for approximately $10.11.

How much money does ACM Research make?

ACM Research (NASDAQ:ACMR) has a market capitalization of $554.53 million and generates $388.83 million in revenue each year. The specialty retailer earns $39.26 million in net income (profit) each year or $0.79 on an earnings per share basis.

How many employees does ACM Research have?

The company employs 1,209 workers across the globe.

How can I contact ACM Research?

ACM Research's mailing address is 42307 OSGOOD ROAD SUITE I, FREMONT CA, 94539. The official website for the company is www.acmrcsh.com. The specialty retailer can be reached via phone at (510) 445-3700, via email at gary@blueshirtgroup.com, or via fax at 510-445-3708.

This page (NASDAQ:ACMR) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -